If You Invested in Femto Technologies Inc. (BCAN)

BCAN is the Nasdaq trading symbol that historically represented BYND Cannasoft Enterprises Inc., an Israeli-based integrated software and cannabis company. According to multiple company press releases, BYND Cannasoft develops, markets, and sells proprietary customer relationship management (CRM) software and is also active in medical cannabis-related activities and sexual wellness technology. Subsequent SEC filings show that the reporting issuer later became known as Femto Technologies Inc. (formerly BYND Cannasoft Enterprises Inc.), so BCAN is best understood as the ticker associated with the BYND Cannasoft phase of the company’s history.

Business focus and core activities

Press releases describe BYND Cannasoft as owning and marketing "Benefit CRM", a proprietary CRM software product. Benefit CRM is aimed at small and medium-sized businesses and is used to optimize day-to-day business activities such as sales management, personnel management, marketing, call center activities, and asset management. The company states that it has around 20 years of experience in CRM software and is building on this background to develop new platforms.

In addition to its general-purpose CRM offering, BYND Cannasoft is developing a new CRM platform for the medical cannabis industry. Company disclosures explain that this Cannabis CRM System is intended to make the medical cannabis market more organized, accessible, and price-transparent. The planned system architecture includes a Job Management component (referred to as BENEFIT) and a module system (referred to as CANNASOFT) for managing farms and greenhouses with varied crops.

Cannabis-related operations

BYND Cannasoft describes itself as an integrated software and cannabis company. Press releases note that the company manages the construction, licensing, and operation of a cannabis farm and indoor cannabis growing facility. In a separate disclosure, the company reports that the Medical Cannabis Unit at the Ministry of Health of the State of Israel issued it a full license to engage in medical cannabis without direct contact with the substance. This license allows BYND Cannasoft to trade in medical cannabis products through an agreement with a licensed cannabis grower in Israel.

The company has also indicated that it submitted a research and development plan to develop CRM software combined with artificial intelligence for the medical cannabis industry under an Israel Innovation Authority grant program. These activities position BYND Cannasoft at the intersection of software, data, and regulated medical cannabis markets, as described in its own communications.

EZ-G device and sexual wellness technology

A distinctive element of BYND Cannasoft’s business, as detailed in multiple press releases, is its ownership of patent-pending intellectual property for the EZ-G device. The EZ-G device is described as a therapeutic device that uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system. Company statements indicate that this is intended to potentially treat a wide variety of women’s health issues, subject to regulatory approvals.

The EZ-G device is also characterized as incorporating technological advancements as a sex toy with a more realistic experience. Disclosures explain that the prototype utilizes sensors such as pressure, temperature, conductivity, and heart rate sensors to determine what enhances users’ pleasure. The device can be controlled via a Bluetooth app installed on a smartphone or other portable device, with data transmitted to and from a secure cloud using artificial intelligence. According to the company, this data is combined with anonymized user preferences to improve operation and increase sexual satisfaction.

Press releases further describe the development of additional AI-based smart treatment devices for men and for external use for women, also targeting the sexual wellness and treatment space. BYND Cannasoft, through its subsidiary Zigi Carmel Initiatives & Investments LTD, has filed multiple patent applications related to these technologies, including provisional U.S. patent applications and a PCT application for the EZ-G device, as well as design applications in China.

Geographic footprint and listings

Company announcements consistently identify BYND Cannasoft as an Israeli-based technology and cannabis company with ties to both Ashkelon, Israel and Vancouver, British Columbia. The stock has been referenced as trading on Nasdaq under the symbol BCAN and on the CSE under the symbol BYND. Later SEC filings refer to Femto Technologies Inc. (formerly known as BYND Cannasoft Enterprises Inc.) as a foreign private issuer reporting under the Securities Exchange Act of 1934.

Intellectual property and R&D

BYND Cannasoft’s press releases emphasize its intellectual property strategy around the EZ-G device and related technologies. The company reports filing a national phase application for the EZ-G device in multiple jurisdictions, including a U.S. utility patent application under the Patent Prosecution Highway and an application with the European Patent Office. It also notes filing provisional patent applications in the United States and design applications in China.

The WIPO publication for the EZ-G device (Publication Number WO/2023/13195) is described as relating to adult toys utilizing one or more sensors for controllable operation and a liquid administering mechanism. The company states that it is collaborating with legal experts to navigate patent prosecution and that it views expanded IP protection as important for the valuation of the business.

Capital markets activity

News releases linked to BCAN report several capital raising transactions. Aegis Capital Corp. is noted as acting as sole bookrunner on a US$7.0 million underwritten public offering for BYND Cannasoft Enterprises Inc. and as exclusive placement agent on a US$1.5 million registered direct offering. The company has also disclosed a separate firm commitment underwritten public offering with gross proceeds of approximately US$2.6 million before expenses. BYND Cannasoft has indicated that proceeds from these offerings are intended for product design and manufacturing, sales and marketing campaigns, patent prosecution, and working capital.

Regulatory and corporate evolution

Subsequent SEC filings on Form 6-K identify the reporting issuer as Femto Technologies Inc. (formerly known as BYND Cannasoft Enterprises Inc.), with a Commission File Number of 001-41408. These filings document the change of name and ongoing reporting as a foreign private issuer. They also reference the filing of consolidated financial statements and management discussion and analysis for later periods under the new corporate name. This indicates that the entity associated with BCAN underwent a corporate name change to Femto Technologies Inc., while maintaining its reporting obligations.

How BCAN fits into the broader market

From the information in company communications and filings, BCAN historically provided investors with exposure to a combination of CRM software for small and medium-sized enterprises, specialized CRM and licensing activities in the medical cannabis sector, and AI-enabled sexual wellness and therapeutic devices. The company’s disclosures highlight its focus on proprietary software, regulated medical cannabis trading under license in Israel, and patent-backed hardware devices that integrate sensors, cloud connectivity, and artificial intelligence.